Comment: LUMINA results show that women with low levels of the Ki67 biomarker can avoid outcomes related to radiotherapy

Share :
Published: 9 Jun 2022
Views: 247
Dr Corey Wayne Speers - University of Michigan, Ann Arbor, USA

Dr Corey Wayne Speers comments on the LUMINA study findings.

The study showed based on guidance from biomarker screening, patients who are 55 years of age and older with low-grade luminal A-type breast cancer may only need endocrine therapy following breast conserving surgery and could avoid radiation therapy entirely.

Dr Speers also discusses other similar future trials that aim to identify which subgroups of patients may be able to avoid a radiotherapy treatment option.

The patients in the study will continue to be followed for up to 10 years for effects on long term recurrence and survival.  

Watch our interview with Dr Whelan here

Watch Dr Whelan's press conference on the study here

Watch Dr Bishal Gyawali comment on the study here

Read our news story about the study here